Professor

Scott Bell

Email: 

Availability

Professor Scott Bell is:
Available for supervision

Fields of research

Clinical sciences Medical microbiology

Search Professor Scott Bell’s works on UQ eSpace

416 works between 1991 and 2025
All (416) Journal Article (299) Book Chapter (6) Conference Publication (111)

281 - 300 of 416 works

2006

Journal Article

Protease IV production in Pseudomonas aeruginosa from the lungs of adults with cystic fibrosis

Smith, Lucas, Rose, Barbara, Tingpej, Pholawat, Zhu, Hua, Conibear, Tim, Manos, Jim, Bye, Peter, Elkins, Mark, Willcox, Mark, Bell, Scoot, Wainwright, Claire and Harbour, Colin (2006). Protease IV production in Pseudomonas aeruginosa from the lungs of adults with cystic fibrosis. Journal of Medical Microbiology, 55 (12), 1641-1644. doi: 10.1099/jmm.0.46845-0

Protease IV production in Pseudomonas aeruginosa from the lungs of adults with cystic fibrosis

2006

Journal Article

Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosis

Buntain, H. M., Schluter, P. J., Bell, S. C., Greer, R. M., Wong, J. C. H., Batch, J., Lewindon, P. and Wainwright, C. E. (2006). Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosis. Thorax, 61 (2), 146-154. doi: 10.1136/thx.2005.046516

Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosis

2006

Journal Article

Epidemiological analysis of methicillin-resistant Staphylococcus aureus isolates from adult patients with cystic fibrosis

Kidd, T. J., Coulter, C. and Bell, S. C. (2006). Epidemiological analysis of methicillin-resistant Staphylococcus aureus isolates from adult patients with cystic fibrosis. Infection Control and Hospital Epidemiology, 27 (2), 201-203. doi: 10.1086/501173

Epidemiological analysis of methicillin-resistant Staphylococcus aureus isolates from adult patients with cystic fibrosis

2006

Conference Publication

Pharmacokinetic study of itraconazole leads to new improved dosing regimens for paediatric cystic fibrosis and bone marrow transplant patients

Hennig, S, Wainwright, C E, Bell, S, Miller, H, Friberg, L. E. and Charles, B G (2006). Pharmacokinetic study of itraconazole leads to new improved dosing regimens for paediatric cystic fibrosis and bone marrow transplant patients. The 6th Annual Health and Medical Research Conference of Queensland, Brisbane, Australia, 23-24 November 2006. Brisbane, Australia: Queensland Health.

Pharmacokinetic study of itraconazole leads to new improved dosing regimens for paediatric cystic fibrosis and bone marrow transplant patients

2006

Conference Publication

A D-optimal designed population pharmacokinetic study of itraconazole capsules and solution in adults with cystic fibrosis

Hennig, S., Wainwright, C. E., Bell, S., Miller, H., Charles, B. G. and Duffull, S. B. (2006). A D-optimal designed population pharmacokinetic study of itraconazole capsules and solution in adults with cystic fibrosis. 15th Annual Meeting of the Population Approach Group in Europe, Bruges, Belgium, 14-16 June 2006. PAGE.

A D-optimal designed population pharmacokinetic study of itraconazole capsules and solution in adults with cystic fibrosis

2006

Journal Article

Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients

Hennig, S., Wainwright, C. E., Bell, S. C., Miller, H., Friberg, L. E. and Charles, B. G. (2006). Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients. Clinical Pharmacokinetics, 45 (11), 1099-1114. doi: 10.2165/00003088-200645110-00004

Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients

2006

Conference Publication

Paediatric population pharmacokinetcis (popPK) of itraconazole (ITRA) and its active metabolite hydroxy-itraconazole in cystic fibrosis (CF) and bone marrow transplant patients (BMT)

Hennig, S, Wainwright, C E, Bell, S, Miller, H, Friberg, L. E. and Charles, B G (2006). Paediatric population pharmacokinetcis (popPK) of itraconazole (ITRA) and its active metabolite hydroxy-itraconazole in cystic fibrosis (CF) and bone marrow transplant patients (BMT). PAGANZ 06 9th Annual Scientific Meeting, Auckland New Zealand / School of Medicine, 7-9 February 2006. Brisbane, Australia: Poppulation Approach Group in Australia and New Zealand.

Paediatric population pharmacokinetcis (popPK) of itraconazole (ITRA) and its active metabolite hydroxy-itraconazole in cystic fibrosis (CF) and bone marrow transplant patients (BMT)

2006

Book Chapter

Cystic Fibrosis Infection with Clonal Strains of Pseudomonas Aeruginosa: Current Knowledge and Future Management

Jones, A. M. and Bell, S. C. (2006). Cystic Fibrosis Infection with Clonal Strains of Pseudomonas Aeruginosa: Current Knowledge and Future Management. Cystic Fibrosis. (pp. 105-126) edited by K. Webb and F. Ratjen. London: Maney Publishing.

Cystic Fibrosis Infection with Clonal Strains of Pseudomonas Aeruginosa: Current Knowledge and Future Management

2006

Conference Publication

Paediatric population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in cystic fibrosis and bone marrow transplant patients

Hennig, S., Wainwright, C. E., Bell, S. C., Miller, H., Friberg, L. E. and Charles, B. G. (2006). Paediatric population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in cystic fibrosis and bone marrow transplant patients. Population Approach Group Europe: 15th Meeting, Bruges, Belgium, 14-16 June 2006. PAGE.

Paediatric population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in cystic fibrosis and bone marrow transplant patients

2006

Journal Article

Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteria

Block, J. K., Vandemheen, K. L., Tullis, E., Fergusson, D., Doucette, S., Haase, D., Berthiaume, Y., Brown, N., Wilcox, P., Bye, P., Bell, S., Noseworthy, M., Pedder, L., Freitag, A. and Paterson, N. (2006). Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteria. Thorax, 61 (11), 969-974. doi: 10.1136/thx.2006.061366

Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteria

2006

Conference Publication

A D-optimal designed population pharmacokinetic study of itraconazole

Hennig, S, Wainwright, C E, Bell, S, Miller, H, Charles, B G and Duffull, S B (2006). A D-optimal designed population pharmacokinetic study of itraconazole. APSA Annual Meeting 2006, Adelaide, Australia, 2-5 December 2006. Adelaide:

A D-optimal designed population pharmacokinetic study of itraconazole

2005

Journal Article

Antibiotic susceptibilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions

Hill, Dominic, Rose, Barbara, Pajkos, Aniko, Robinson, Michael, Bye, Peter, Bell, Scott C., Elkins, Mark, Thompson, Barbara, MacLeod, Colin, Aaron, Shawn D. and Harbour, Colin (2005). Antibiotic susceptibilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions. Journal of Clinical Microbiology, 43 (10), 5085-5090. doi: 10.1128/JCM.43.10.5085-5090.2005

Antibiotic susceptibilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions

2005

Journal Article

MRSA eradication in a health care worker with cystic fibrosis; re-emergence or re-infection?

Downey, D. G., Kidd, T. J., Coulter, C. and Bell, S. C. (2005). MRSA eradication in a health care worker with cystic fibrosis; re-emergence or re-infection?. Journal of Cystic Fibrosis, 4 (3), 205-207. doi: 10.1016/j.jcf.2005.05.014

MRSA eradication in a health care worker with cystic fibrosis; re-emergence or re-infection?

2005

Journal Article

Pubertal development and its influences on bone mineral density in Australian children and adolescents with cystic fibrosis

Buntain, Helen M., Greer, Ristan M., Wong, Joseph C.H., Schluter, Philip J., Batch, Jennifer, Lewindon, Peter, Bell, Scott C. and Wainwright, Claire E. (2005). Pubertal development and its influences on bone mineral density in Australian children and adolescents with cystic fibrosis. Journal of Paediatrics And Child Health, 41 (7), 317-322. doi: 10.1111/j.1440-1754.2005.00635.x

Pubertal development and its influences on bone mineral density in Australian children and adolescents with cystic fibrosis

2005

Journal Article

Has the time come to prescribe azithromycin in cystic fibrosis patients?

McCormack, J. G. and Bell, S. C. (2005). Has the time come to prescribe azithromycin in cystic fibrosis patients?. Internal Medicine Journal, 35 (2), 73-74. doi: 10.1111/j.1445-5994.2004.00762.x

Has the time come to prescribe azithromycin in cystic fibrosis patients?

2005

Conference Publication

Transient non-genomovar III Burkholderia cepacia infection is not uncommon in adults with cystic fibrosis

Kermeen, F. D., Kim, S. T., Kidd, T. J., Coulter, C., Greer, R. M. and Bell, S. C. (2005). Transient non-genomovar III Burkholderia cepacia infection is not uncommon in adults with cystic fibrosis. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, WA, Australia, 18-23 March 2005. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1

Transient non-genomovar III Burkholderia cepacia infection is not uncommon in adults with cystic fibrosis

2005

Conference Publication

Antibiotics in cystic fibrosis (CF): A systematic review

Kim, S. T., Yang, I. A. and Bell, S. C. (2005). Antibiotics in cystic fibrosis (CF): A systematic review. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1

Antibiotics in cystic fibrosis (CF): A systematic review

2005

Conference Publication

Antibiotics in cystic fibrosis (CF): A systematic review

Kim, S. T., Yang, I. A. and Bell, S. C. (2005). Antibiotics in cystic fibrosis (CF): A systematic review. Array, Crete, Greece, 22-25 Jun, 2005. Amsterdam, Netherlands: Elsevier BV.

Antibiotics in cystic fibrosis (CF): A systematic review

2005

Journal Article

Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multi-resistant bacteria: A randomised, double-blind, controlled clinical trial

Aaron, Shawn D., Vandemheen, Katherine L., Ferris, Wendy, Fergusson, Dean, Tullis, Elizabeth, Haase, David, Berthiaume, Yves, Brown, Neil, Wilcox, Pearce, Yozghatlian, Veronica, Bye, Peter, Bell, Scott, Chan, Francis, Rose, Barbara, Jeanneret, Alphonse, Stephenson, Anne, Noseworthy, Mary, Freitag, Andreas, Paterson, Nigel, Doucette, Steve, Harbour, Colin, Ruel, Michel and MacDonald, Noni (2005). Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multi-resistant bacteria: A randomised, double-blind, controlled clinical trial. The Lancet, 366 (9484), 463-471. doi: 10.1016/S0140-6736(05)67060-2

Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multi-resistant bacteria: A randomised, double-blind, controlled clinical trial

2005

Conference Publication

A study of allergic reactions to beta-lactam antibiotics in an adult cystic fibrosis unit

Burrows, J., Nissen, L. M., Kirkpatrick, C. M. J. and Bell, S. C. (2005). A study of allergic reactions to beta-lactam antibiotics in an adult cystic fibrosis unit. Sixth Australian & New Zealand Cystic Fibrosis Conference, Adelaide, 20-23 Aug. 2005. Australia:

A study of allergic reactions to beta-lactam antibiotics in an adult cystic fibrosis unit

Current funding

  • 2025 - 2028
    Combating pathogens from biofilms in premise plumbing systems
    ARC Linkage Projects
    Open grant
  • 2023 - 2026
    Making Australia resilient to airborne infection transmission (ARC Linkage Project administered by Queensland University of Technology)
    Queensland University of Technology
    Open grant
  • 2019 - 2025
    Queensland cystic fibrosis research program
    The Children's Hospital Foundation
    Open grant
  • 2018 - 2025
    Multi-drug resistant non-tuberculous mycobacteria infection research
    Research Donation Generic
    Open grant

Past funding

  • 2021 - 2023
    Prevention of SARS-CoV-2 transmission in aged care (PETRA formerly PreSTAC): Effective evidence-based measures for rapid translation - External led SAHMRI
    South Australian Health and Medical Research Institute Limited
    Open grant
  • 2020
    BD Bactec MGIT 320 System
    Prince Charles Hospital Foundation
    Open grant
  • 2020 - 2023
    The emerging problem of non-tuberculous mycobacteria infection: Understanding aetiology, geospatial epidemiology and developing interventions
    NHMRC Project Grant
    Open grant
  • 2019 - 2025
    Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMAT)
    Cystic Fibrosis Foundation USA
    Open grant
  • 2019 - 2024
    Early life origins of cystic fibrosis lung disease
    Cystic Fibrosis Foundation USA
    Open grant
  • 2019
    Establishing UQ Centre for Clinical Research as the centre for Aerosol therapy in critical care by optimising particle size of aerosols for effective drug delivery.
    UQ Major Equipment and Infrastructure
    Open grant
  • 2018 - 2021
    Enhancing detection and management of Mycobacterium abscessus complex (MABSC) infection in children with cystic fibrosis
    The Children's Hospital Foundation
    Open grant
  • 2016 - 2019
    Macrophages: the forgotten cells in CF lung disease
    Cystic Fibrosis Foundation Therapeutics Inc
    Open grant
  • 2016 - 2020
    The acquired resistome of Pseudomonas aeruginosa strains in people with cystic fibrosis (Joint UQ/QIMR AID seed grant awarded to QIMRB)
    Queensland Institute of Medical Research
    Open grant
  • 2016 - 2019
    The emerging problem of non-tuberculous mycobacteria infection: understanding aetiology, geospatial epidemiology and developing interventions (NHMRC Project led by QIMR Berghofer)
    Queensland Institute of Medical Research
    Open grant
  • 2015 - 2017
    Abnormal lung iron homeostasis in cystic fibrosis (NHMRC Project Grant administered by QIMR)
    Queensland Institute of Medical Research
    Open grant
  • 2014 - 2016
    Intra-strain diversity of Pseudomonas aeruginosa in the lungs of patients with CF and their role in exacerbation
    Prince Charles Hospital Foundation
    Open grant
  • 2013 - 2014
    Purchase of -80C Freezer - XYCYST
    Prince Charles Hospital Foundation
    Open grant
  • 2012 - 2014
    Airborne Infection Transport in Hospitals
    Prince Charles Hospital Foundation
    Open grant
  • 2010 - 2016
    Inflammatory airways disease in children with a focus on cystic fibrosis
    Royal Children's Hospital Foundation
    Open grant
  • 2010 - 2011
    Longitudinal study of clonal Pseudomonas aeruginosa in cystic fibrosis
    Queensland Health
    Open grant
  • 2010 - 2011
    Development of a novel assay for the detection of clonal P.aeruginosa in persons with CF
    Australian Cystic Fibrosis Research Trust
    Open grant
  • 2010 - 2011
    Longitudinal study of clonal Pseudomonas aeruginosa in cystic fibrosis
    Royal Children's Hospital Foundation
    Open grant
  • 2009 - 2015
    A statewide, electronic, disease specific, clinical record/database for children and adults with cystic fibrosis (electronic medical record for cystic fibrosis)
    Royal Children's Hospital Foundation
    Open grant
  • 2007 - 2010
    Clinical impact of clonal Pseudomonas aeruginosa in cystic fibrosis
    NHMRC Project Grant
    Open grant
  • 2005 - 2010
    How Children and adults with cystic fibrosis get lung infections with Pseudomonas aeruginosa
    Royal Children's Hospital Foundation
    Open grant

Availability

Professor Scott Bell is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Risk and mitigation of cough aerosols for people with cystic fibrosis.

    Principal Advisor

    Other advisors: Professor Rachel Thomson

  • Doctor Philosophy

    The Pharmacokinetics & Pharmacodynamics of Antimycobacterial Drugs in People with Cystic Fibrosis and Drug-Resistant Tuberculosis Infection

    Associate Advisor

    Other advisors: Professor Rachel Thomson, Professor Jason Roberts

Completed supervision

Enquiries

For media enquiries about Professor Scott Bell's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au